Recent studies provided genetic evidence that RB1 and p130 have the capacity to act as suppressors of lung adenocarcinoma development, confirming the broad tumor-suppressor potential of the RB family genes and raising the possibility that re-activation or induction of RB family function in lung cancers may be used to slow tumor growth in patients [41]. The gene discussed is RB1; the disease is neoplasm.